IBRN PE Ratio & Valuation, Is IBRN Overvalued

Performance Decomposition

AI Analysis

Market capitalization of IBRN increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of IBRN in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is IBRN currently overvalued or undervalued?

iShares Neuroscience and Healthcare ETF (IBRN) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of --. The fair price of iShares Neuroscience and Healthcare ETF (IBRN) is between -- to -- according to relative valuation method.

What is iShares Neuroscience and Healthcare ETF (IBRN) fair value?

IBRN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of iShares Neuroscience and Healthcare ETF (IBRN) is between -- to -- according to relative valuation method.

How does IBRN's valuation metrics compare to the industry average?

The average P/S ratio for IBRN's competitors is 0.00, providing a benchmark for relative valuation. iShares Neuroscience and Healthcare ETF Corp (IBRN) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for iShares Neuroscience and Healthcare ETF (IBRN) as of Mar 05 2026?

As of Mar 05 2026, iShares Neuroscience and Healthcare ETF (IBRN) has a P/B ratio of NaN. This indicates that the market values IBRN at NaN times its book value.

What is the current FCF Yield for iShares Neuroscience and Healthcare ETF (IBRN) as of Mar 05 2026?

As of Mar 05 2026, iShares Neuroscience and Healthcare ETF (IBRN) has a FCF Yield of NaN%. This means that for every dollar of iShares Neuroscience and Healthcare ETF's market capitalization, the company generates NaN cents in free cash flow.

What is the current Forward P/E ratio for iShares Neuroscience and Healthcare ETF (IBRN) as of Mar 05 2026?

As of Mar 05 2026, iShares Neuroscience and Healthcare ETF (IBRN) has a Forward P/E ratio of NaN. This means the market is willing to pay $NaN for every dollar of iShares Neuroscience and Healthcare ETF's expected earnings over the next 12 months.

What is the current Forward P/S ratio for iShares Neuroscience and Healthcare ETF (IBRN) as of Mar 05 2026?

As of Mar 05 2026, iShares Neuroscience and Healthcare ETF (IBRN) has a Forward P/S ratio of NaN. This means the market is valuing IBRN at $NaN for every dollar of expected revenue over the next 12 months.

IBRN Valuation